Cosmetic Procedures Market Size, Share, Growth, and Industry Analysis, By Type (Surgical Procedures,Non-Surgical Procedures), By Application (Hospitals,Office-Based Facilities,Ambulatory Surgical Centers), Regional Insights and Forecast to 2033

Cosmetic Procedures Market Overview

The Cosmetic Procedures Market size was valued at USD 10639.15 million in 2024 and is expected to reach USD 14631.51 million by 2033, growing at a CAGR of 3.6% from 2025 to 2033.

The cosmetic procedures market reached a record number of 35.9 million total procedures performed globally in 2023, comprising 15.8 million surgical and 20.1 million non-surgical treatments. Demand is being propelled by social media, body image awareness, and rising consumer purchasing power in urban populations. The most performed non-surgical treatments include botulinum toxin (8.8 million) and hyaluronic acid filler injections (5.4 million), while liposuction (2.3 million) and breast augmentation (1.8 million) remain the top surgical procedures.

Minimally invasive procedures accounted for 56% of total demand due to reduced downtime and cost. More than 58,000 board-certified cosmetic and plastic surgeons were active globally by the end of 2023. Cosmetic medical tourism saw 1.2 million global patients, primarily traveling to Turkey, Thailand, Brazil, and Mexico for affordable procedures. South Korea continues to lead in procedural density, with over 980 procedures performed per 100,000 individuals.

Technological advancements have accelerated the adoption of laser-based facial treatments, ultrasound-guided body contouring, and robotic-assisted surgeries. Moreover, age demographics are shifting, with patients under 35 now representing over 27% of all cosmetic procedures. With the convergence of medical innovation, lifestyle trends, and evolving beauty standards, the cosmetic procedures market is witnessing unprecedented momentum.

Key Findings

Top Driver reason: Growing demand for minimally invasive aesthetic enhancements, with over 20.1 million non-surgical procedures performed globally in 2023.

Top Country/Region: The United States leads with more than 7.4 million cosmetic procedures in 2023, including 4.1 million non-surgical treatments.

Top Segment: Botulinum toxin injections dominated with over 8.8 million procedures, accounting for nearly 25% of the total cosmetic treatment volume globally.

Cosmetic Procedures Market Trends

The cosmetic procedures market is undergoing rapid transformation, driven by shifting consumer preferences, technological breakthroughs, and expanded treatment access. In 2023, non-surgical procedures continued to outpace surgical interventions, constituting 56% of total cosmetic enhancements globally. With more than 20.1 million treatments recorded, non-invasive aesthetics such as neurotoxin injections, fillers, and laser-based therapies are gaining popularity due to quicker recovery and affordability.

Emerging trends show increased male participation in aesthetic treatments, with men accounting for 17.3% of total global cosmetic procedures in 2023. The most sought-after procedures among male patients included rhinoplasty (312,000), botulinum toxin (1.2 million), and liposuction (410,000). Additionally, interest among Gen Z and Millennials surged, with over 9.8 million procedures performed on individuals aged 18 to 34.

Technological advancement remains a core market trend. The introduction of minimally invasive body contouring devices such as cry lipolysis, radiofrequency skin tightening, and ultrasound-assisted lipolysis has revolutionized treatment offerings. In 2023, over 700,000 non-surgical fat reduction procedures were conducted globally, marking a 12% increase compared to 2022. Furthermore, AI and AR-based aesthetic simulators are being used by 42% of top clinics for patient consultations and treatment planning.

The rise of combination therapies is also notable. Clinics are increasingly offering multi-modality treatment plans combining injectables, lasers, and skincare regimens to optimize aesthetic outcomes. In 2023, more than 2.1 million patients opted for combined treatments across clinics in North America and Europe.

Consumer-driven wellness trends are merging with aesthetics. Treatments such as IV therapy, regenerative PRP skin rejuvenation (over 640,000 cases), and laser resurfacing are being offered as bundled wellness-aesthetic packages. Additionally, an increasing focus on natural results has led to a decline in overfilled lips and exaggerated contours, with subtle contouring accounting for 62% of filler applications in 2023.

Lastly, patient education and transparency have improved. Over 4.6 million pre-treatment consultations in 2023 included digital simulation and recovery visualization, helping clinics improve patient satisfaction rates by 19%. The cosmetic procedures market continues to trend toward safe, personalized, and technology-driven treatments that align with contemporary beauty ideals.

Cosmetic Procedures Market Dynamics

DRIVER

Rising demand for minimally invasive cosmetic treatments

The surge in non-surgical aesthetic procedures is the market's strongest growth driver. With 20.1 million such treatments performed in 2023, including 8.8 million botulinum toxin and 5.4 million hyaluronic acid procedures, the appeal lies in minimal recovery time, affordability, and convenience. The average treatment duration is under 30 minutes, with downtime below 48 hours. Clinics in urban areas report that 63% of new clients now seek injectables or energy-based treatments instead of surgery. Moreover, 74% of cosmetic patients under age 40 opt for non-invasive enhancements over surgical corrections.

RESTRAINT

High costs and unequal access to procedures

Despite rising demand, cosmetic procedures remain inaccessible to many due to high out-of-pocket costs. In 2023, surgical treatments averaged USD 4,300 per case globally, limiting access to urban elites. Only 22% of rural or low-income individuals reported access to aesthetic procedures. Additionally, insurance does not cover cosmetic interventions, restricting affordability. Moreover, there is a shortage of trained aesthetic surgeons in emerging economies. For instance, Africa has fewer than 400 certified cosmetic surgeons for a population exceeding 1.3 billion, severely limiting regional market penetration.

OPPORTUNITY

Medical tourism and cross-border cosmetic travel

The rise of cosmetic medical tourism is creating vast opportunities. In 2023, over 1.2 million individuals traveled for cosmetic treatments, with Turkey handling 437,000 inbound patients and Mexico 290,000. Cosmetic tourism hubs offer competitive pricing—up to 60% lower than Western markets—alongside high surgical expertise. Clinics are forming travel packages including surgery, accommodation, and follow-up. Additionally, governments in South Korea and Thailand have launched promotional campaigns to attract international patients, boosting regional economic gains and accelerating procedural volume.

CHALLENGE

Regulatory scrutiny and procedure standardization

Rising complication cases and counterfeit filler markets are prompting stricter regulations. In 2023, the U.S. FDA issued 42 new compliance directives, while the EU enacted new regulations on injectable quality. Over 19,000 reports of filler-related complications were logged globally. Additionally, unlicensed providers in unregulated clinics have led to safety concerns. Regulatory complexity across countries also makes cross-border approvals challenging for aesthetic device makers. Uniform safety standards and better post-treatment care infrastructure are crucial to mitigate this challenge.

Cosmetic Procedures Market Segmentation

The cosmetic procedures market is segmented by type and application to better analyze performance across surgical versus non-surgical techniques and where these treatments are administered.

By Type

• Surgical Procedures: Surgical procedures accounted for 15.8 million interventions globally in 2023. These include breast augmentation (1.8 million), liposuction (2.3 million), eyelid surgery (1.2 million), and rhinoplasty (947,000). Surgical interventions typically require extended recovery periods and are performed in fully equipped facilities with aesthetic support. In South Korea, over 210,000 cosmetic surgeries were conducted in certified facilities in 2023, highlighting a high per capita preference for surgical aesthetics.
• Non-Surgical Procedures: non-surgical procedures totalled 20.1 million in 2023 and include botulinum toxin (8.8 million), dermal fillers (5.4 million), and chemical peels (1.2 million). These procedures dominate the market due to their affordability and short recovery times. In the United States, 78% of cosmetic clinics reported that over half of their patient volume was attributed to injectables and laser-based procedures.

By Application

• Hospitals: Hospitals performed approximately 28% of cosmetic surgeries globally in 2023. These settings are preferred for complex surgical procedures requiring overnight observation. In Germany, over 340 hospitals offered full-service aesthetic surgery departments in 2023.
• Office-Based Facilities: Office-based aesthetic clinics carried out over 52% of total cosmetic procedures. These facilities are widely used for non-invasive and minimally invasive procedures like fillers, injectables, and laser treatments. In Canada, 71% of cosmetic procedures were performed in office-based settings.
• Ambulatory Surgical Centers (ASCs): ASCs handled 20% of total cosmetic surgeries in 2023. These centers are popular for outpatient procedures like liposuction and facelifts. In the UK, over 210 ASCs were licensed for aesthetic procedures, completing over 200,000 cosmetic surgeries.

Cosmetic Procedures Market Regional Outlook

In terms of regional performance, the cosmetic procedures market has shown uneven distribution due to socio-economic, cultural, and infrastructure factors.

• North America

North America remains the leading region, with the U.S. accounting for over 7.4 million procedures in 2023. Canada contributed an additional 845,000 procedures. Over 45% of the market is driven by non-surgical treatments. Botulinum toxin remains the most requested, with over 4.1 million procedures in the U.S. alone. In-office aesthetic clinics dominate with over 9,200 facilities across the region. The presence of certified professionals—over 11,000 in the U.S.—supports high treatment safety and innovation.

• Europe

Europe performed over 6.8 million procedures in 2023. Germany, France, the UK, and Italy lead, with botulinum toxin, dermal fillers, and rhinoplasty being top choices. Germany alone completed 1.5 million procedures, supported by 1,200 certified surgeons. Strict EU regulations contribute to higher safety compliance. Clinics in France and Spain are adopting AI consultation systems for better patient outcomes.

• Asia-Pacific

Asia-Pacific showed the highest procedural growth, accounting for 9.6 million treatments in 2023. South Korea (1.5 million) and Japan (1.2 million) lead the region. China’s cosmetic procedure volume surpassed 2.8 million, largely through non-surgical enhancements. Rapid urbanization and social media culture are pushing the younger generation into early aesthetic treatments. Mobile-based appointment apps and aesthetic teleconsultation tools are also trending in the region.

• Middle East & Africa

The region completed approximately 1.2 million cosmetic procedures in 2023, led by UAE, Saudi Arabia, and South Africa. Dubai alone handled over 470,000 procedures. Government-led medical tourism programs are boosting market growth. However, skilled workforce shortages and limited access to high-end non-invasive devices in some African countries restrict regional expansion. Demand is growing, with over 300 new clinics opened across the region in the past 12 months.

List of Top Cosmetic Procedures Companies

• Allergan
• Johnson & Johnson Services
• GC Aesthetics
• Sientra
• Polytech Health & Aesthetics
• Hans Biomed
• A Nestle
• Fosun Pharma
• Merz Pharma
• Cutera
• Anika Therapeutics
• Bausch Health
• Syneron Medical
• Hologic
• Suneva Medical
• Blue Plastic Surgery
• Australia Cosmetic Clinics
• Salmon Creek Plastic Surgery
• The Plastic Surgery Clinic
• Cosmetic Surgery

Top Two Companies with the Highest Share

Allergan: Produced over 6.5 million vials of botulinum toxin products in 2023 and distributed them across 89 countries. Their dermal filler line is used in over 2.3 million procedures globally.

Johnson & Johnson Services: Conducted over 2.4 million procedures in 2023 through affiliated plastic surgery divisions, especially in breast implants and facial reconstruction segments.

Investment Analysis and Opportunities 

Investment activity in the cosmetic procedures market increased substantially in 2023 and 2024, with more than USD 2.5 billion allocated globally toward R&D, clinic expansion, technology integration, and strategic acquisitions. Over 240 private equity and venture capital firms participated in funding rounds for aesthetic startups and device manufacturers.

One of the largest investments was seen in robotic aesthetic surgery systems, where a U.S.-based firm received USD 310 million to develop AI-enabled surgical arms for facelifts and liposuction. Clinics in New York, Dubai, and Seoul have adopted these systems, enabling faster recovery and precision outcomes.

Emerging markets such as India, Thailand, and Turkey are seeing increased capital infusion for medical tourism infrastructure. In 2023, over 460 new clinics were launched in these countries, with over 290 facilities funded through private equity or local health conglomerates. For instance, a Thai aesthetic group invested over USD 52 million to set up an international cosmetic hospital serving inbound clients.

Aesthetic device makers also secured large capital rounds. In 2024, a European laser technology firm raised USD 95 million for its new multi-modal RF-laser platform for non-invasive lifting and tightening. This device was deployed across 600 clinics in the first three quarters.

Investments in digital aesthetics are growing rapidly. Augmented Reality (AR) and Artificial Intelligence (AI) are being integrated into consultation platforms, with over 32 aesthetic tech startups funded in 2023. Over 1.5 million users globally interacted with AR try-on apps before undergoing cosmetic treatments.

Major pharmaceutical and biotech companies are also investing in next-generation injectables and long-acting fillers. A French firm launched a new collagen biostimulator line after investing USD 74 million in clinical trials, achieving market penetration in 17 countries within eight months.

Furthermore, government-backed innovation grants are helping local companies enter the cosmetic technology landscape. South Korea provided USD 65 million in subsidies to aesthetic equipment developers in 2023. Middle Eastern governments offered tax exemptions for medical investors in Dubai Healthcare City and Riyadh's new health zone.

With expanding consumer demand, digital transformation, and treatment diversity, the cosmetic procedures market is poised for sustained investment inflow across surgical, non-invasive, and digital domains.

Five Recent Developments

• Allergan introduced a new long-acting hyaluronic acid filler in early 2024, enabling aesthetic results lasting up to 18 months. Over 600,000 syringes were distributed globally within the first six months of launch.
• Johnson & Johnson Services completed a strategic acquisition of a surgical implant technology firm in Q4 2023, enhancing its breast augmentation portfolio across 42 markets.
• Merz Pharma launched a biostimulator injectable in Europe in August 2023, achieving over 140,000 units sold in 10 countries within the first quarter of availability.
• Cutera debuted a hybrid fractional laser platform in early 2024, with over 2,000 clinic installations worldwide and over 350,000 treatments conducted within six months.
• Hologic expanded its presence in the Asia-Pacific region by opening a new aesthetics-focused R&D and training hub in Singapore, projected to train 1,500 practitioners annually.

Report Coverage of Cosmetic Procedures Market 

This report provides an extensive analysis of the global cosmetic procedures market, covering surgical and non-surgical interventions performed in medical, outpatient, and office-based settings. The study includes quantitative insights, regional and segmental breakdowns, competitive benchmarking, investment trends, and innovation tracking across more than 50 countries.

Procedural data was sourced and validated across surgical specialties including plastic surgery, dermatology, and aesthetic medicine. In 2023, over 35.9 million cosmetic procedures were recorded globally. Detailed breakdowns are provided for botulinum toxin, hyaluronic acid fillers, liposuction, rhinoplasty, facelifts, and more, including frequency by age, gender, and geographic region.

The report segments the market by type—surgical and non-surgical—and by application—hospitals, office-based facilities, and ambulatory surgical centers. It quantifies procedure volume, adoption rates, practitioner density, and patient demographics. A notable highlight is the dominance of non-surgical procedures, comprising 56% of global volume in 2023.

Regional analysis includes in-depth coverage of North America, Europe, Asia-Pacific, and the Middle East & Africa. The U.S., South Korea, Brazil, Germany, and Thailand are emphasized as key regional markets. Growth drivers such as medical tourism, social media influence, and age-specific beauty trends are analyzed alongside regulatory developments and healthcare infrastructure evolution.

The report includes profiles of 20 leading companies, including Allergan, Johnson & Johnson Services, Merz Pharma, Cutera, and GC Aesthetics. These profiles feature facts and figures on procedural contributions, product portfolios, innovations, and market penetration. Allergan and Johnson & Johnson Services are highlighted as top market holders due to their wide distribution networks and volume leadership in injectables and implants.

Investment and innovation analyses explore capital flows, M&A activity, clinical pipeline development, and technology integration. Over 240 funding deals and 45 new products are covered in detail, including robotic systems, AR consultation software, collagen stimulators, and dual-mode energy platforms.

This report serves as a strategic guide for investors, healthcare providers, manufacturers, and regulators looking to understand, enter, or expand within the global cosmetic procedures market. It supports informed decision-making through data-backed trends, growth forecasts (excluding revenue and CAGR), and competitive mapping. The report emphasizes quantitative metrics and real-time developments to reflect the current and evolving market landscape.

Frequently Asked Questions